Market Acess - Swiss Launch

From Approval to Patient Access in Switzerland

Connecting evidence, pricing, reimbursement and stakeholder engagement

Regulatory approval opens the door. Market access determines whether patients can walk trough it.

Your contact: Philipp Ansorge, Function Head Market Access

Approval opens the door. Access decides wheter patients can use it.

In Switzerland, a successful access pathway requires early coordination between evidence, pricing, reimbursement and stakeholder expectations. Companies that address these questions only after regulatory milestones have been reached may face avoidable delays or difficult trade-offs.

At Luminance Health, we support companies in developing practical market-access roadmaps, preparing value and reimbursement dossiers, engaging with relevant stakeholders and navigating pricing and reimbursement discussions. The goal is to connect product strategy with the realities of the Swiss healthcare system and support access for the patients who need innovative therapies.





Evidence

Evidence requirements are clarified before they become critical dependencies.

Pricing

Pricing implications are understood early, not discovered late.

Reimbursement

Reimbursement scenarios are worked out before decisions are locked in.

Stakeholders

Expectations of the relevant stakeholders are known and addressed.

Plan access before it becomes a bottleneck

Addressing access after regulatory milestones

Companies that take this route my face:

  • Avoidable delays

  • Difficult trade-offs

  • Critical dependencies that surface too late

Planning access early

Early planning can help you clarify:

  • Evidence requirements

  • Reimbursement scenarios

  • Pricing implications

  • Potential access pathways

From your challenge to a practical solution

We connect your product strategy with the realities of the Swiss healthcare system, so that innovative therapies can reach the patients who need them.

MARKET-ACCESS ROADMAPS

Your challenge

You need clarity on the access pathway and what it requires from your company.

What we do

We develop practical roadmaps, so that key questions are answered before they become critical dependencies.

  • Evidence requirements

  • Reimbursement scenarios

  • Pricing implications

  • Potential access pathways

MARKET-ACCESS ROADMAPS

Your challenge

You need clarity on the access pathway and what it requires from your company.

What we do

We develop practical roadmaps, so that key questions are answered before they become critical dependencies.

  • Evidence requirements

  • Reimbursement scenarios

  • Pricing implications

  • Potential access pathways